PATENT CLAIM ANALYSIS

Application Number: 16094644
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["424", "470000"]

Abstract:
Described herein are pharmaceutical compositions for the oral administration of mesalazine, as well as methods of making such pharmaceutical compositions, and therapeutic methods for using them. The compositions comprise delayed-immediate release and delayed-extended release formulation of mesalazine.

Claim (Index 62):
The unit dose pharmaceutical product of  claim 42 , wherein the minitablets of (a) and the minitablets of (b) are provided in a sachet, capsule, or vial.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 97.0
- Lexical Diversity: 1.46429
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15076253', '14255529', '14589839', '14230067', '14841428']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7578734605793734
- 35 USC 102 Novelty (BERT): 0.5266605203396639
- Combined Prediction Score: 0.7347521665554024
- Mean Citation Score: 313.1899160000001
- Max Citation Score: 319.44415
- Similarity Product: 181.6528511902064

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test